2326 studies found for:    ovarian cancer
Show Display Options
Rank Status Study
21 Recruiting Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Procedure: ovarian cancer surgery
22 Recruiting Chk1/2 Inhibitor (LY2606368) in Women With BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Non-High Risk Triple Negative Breast Cancer, and High Grade Serous Ovarian Cancer at Low Genetic Risk
Conditions: Ovarian Cancer;   Breast Cancer
Intervention: Drug: LY2606368
23 Terminated Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer
Conditions: Ovarian Cancer;   Epithelial Ovarian Cancer;   Fallopian Tube Carcinoma;   Primary Peritoneal Carcinoma
Interventions: Drug: Lenalidomide, Liposomal Doxorubicin, Bevacizumab;   Drug: Revlimid, Doxil, Avastin
24 Completed Motion Correction in Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) in Ovarian Cancer: A Pilot Study
Condition: Ovarian Cancer
Intervention: Procedure: DCE-MRI scans
25 Recruiting Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer
Conditions: Ovarian Diseases;   Ovarian Neoplasms
Interventions: Other: Laboratory Tumor Marker Analysis;   Other: Transvaginal Ultrasound;   Other: Health Status Questionnaire
26 Recruiting First Line Ovarian Cancer Treatment - Cohort Study
Condition: Epithelial Ovarian Cancer
Intervention: Drug: Bevacizumab
27 Recruiting Detection of Chlamydia DNA by Polymerase Chain Reaction in Primary Tubal and Ovarian Cancers Tissues : a Pilot Study
Condition: Malignant Neoplasm of Fallopian Tube
Intervention: Other: PCR for chlamydia DNA in primary tubal cancer
28 Completed Prostaglandin Metabolite in Urine Samples From Patients With Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Genetic: protein expression analysis;   Other: immunohistochemistry
29 Completed
Has Results
Open Trial of Bendamustine Hydrochloride in Women With Advanced Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Bendamustine HCL
30 Recruiting Observational Retrospective Study on Treatment and Outcomes in Patients With Low-grade Serous Ovarian Cancer
Conditions: Low-grade Serous Ovarian Carcinoma;   Recurrent Invasive Borderline Serous Ovarian Cancer
Intervention:
31 Active, not recruiting AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer
Conditions: Breast Cancer;   Ovarian Cancer
Intervention: Drug: AZ2281 + Carboplatin
32 Recruiting Feasibility Study: Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients
Conditions: Ovarian Cancer;   Primary Peritoneal Carcinoma;   Fallopian Tube Cancer
Interventions: Drug: Propranolol;   Drug: Chemotherapy;   Procedure: Surgery;   Behavioral: Questionnaire
33 Active, not recruiting Chemotherapy-Related Toxicities In Ovarian Cancer Patients
Condition: Ovarian Cancer
Interventions: Behavioral: Interview;   Behavioral: Questionnaire
34 Terminated Seprafilm™ for the Prevention of Intraperitoneal Adhesions and Improved Delivery of Therapy in Women Undergoing Staging and Intraperitoneal Chemotherapy for Advanced Ovarian Cancer
Condition: Epithelial Ovarian Cancer
Intervention: Procedure: Seprafilm™
35 Recruiting BRCA-Screening in Ovarian Cancer
Conditions: BRCA Status;   Ovarian Cancer
Intervention: Genetic: Testing of BRCA status regarding germline and somatic mutation
36 Completed M. D. Anderson Symptom Inventory - Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Behavioral: Interview;   Behavioral: Survey
37 Withdrawn Cost Utility Analysis in Recurrent Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Behavioral: Questionnaire
38 Completed Ovarian Cancer Patient Questionnaire on Genetic Testing
Condition: Ovarian Cancer
Intervention: Behavioral: Questionnaire
39 Completed Whole Body Diffusion MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Ovarian Cancer and Peritoneal Metastasis
Conditions: Ovarian Cancer;   Peritoneal Metastasis
Intervention: Procedure: intravenous contrast administration
40 Not yet recruiting Olaparib Maintenance Treatment Versus Placebo in Patients With PSR Ovarian Cancer Who Are in CR or PR to Platinum-based Chemotherapy and Whose Tumours Carry sBRCAm or HRR-associated Genes Mutations
Condition: Platinum Sensitive Relapsed Ovarian Cancer
Interventions: Drug: OLAPARIB;   Other: PLACEBO

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years